CalciMedica, Inc. (CALC) — Annual Report

Key Insights

• CalciMedica, Inc. (CALC) filed its 10-K report for the fiscal year 2025, providing insight into the company's financial performance and key business developments.
• The filing indicates that CalciMedica is primarily focused on research and development (R&D) activities, with R&D expenses comprising a significant portion of its total expenses.
• The company appears to have utilized various financing activities, including a private placement, an at-the-market offering, and a loan agreement, to fund its operations and R&D efforts.